Gene vaccination for the induction of immune tolerance

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 99-111

  Ferrera, Francesca ^a,c   La Cava, Antonio ^b   Rizzi, Marta ^a,c   Hahn, Bevra H ^b   Indiveri, Francesco ^a,c   Filaci, Gilberto ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

DNA vaccine; Genetic immunization; Plasmid vectors; Regulatory lymphocytes; Tolerance; Viral vectors

Indexed keywords

DNA VACCINE; GENE PRODUCT; IMMUNOLOGIC AGENT; PEPTIDE;

ALLERGIC ENCEPHALITIS; ANTIGEN PRESENTATION; ANTIGEN STRUCTURE; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONFERENCE PAPER; COST; DIABETES MELLITUS; DNA IMMUNIZATION; DRUG EFFECT; DRUG SAFETY; ENGINEERING; EXPERIMENTAL MODEL; GENE EXPRESSION; GENE INDUCTION; GENE TRANSFER; GENETIC IMMUNIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; UVEITIS;

ANIMALIA; MUS;

EID: 35748964166     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.012     Document Type: Conference Paper

References (47)

1. KISIELOW, P. & H. VON BOEHMER. 1995. Development and selection of T cells: facts and puzzles. Adv. Immunol. 58: 87-209.
2. SEBZDA, E. et al. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol. 17: 829-874.
3. HOGQUIST, K., T.A. BALDWIN & S.C. JAMESON. 2005. Central tolerance: learning self-control in the thymus. Nat. Rev. Immunol. 5: 772-782.
4. KYEWSKI, B. & L. KLEIN. 2006. A central role for central tolerance. Annu. Rev. Immunol. 24: 571-606.
5. GAMMON, G. & E. SERCARZ. 1999. How some T cells escape tolerance induction. Nature 342: 183-185.
6. MOUDGIL, K.D. & E.E. SERCARZ. 2000. The self-directed T cell repertoire: its creation and activation. Rev. Immunogenet. 2: 26-37.
7. STREILEIN, J.W., M. TAKEUCHI, & A.W. TAYLOR. 1997. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Human Immunol. 52: 138-143.
8. WALKER, L.S. & A.K. ABBAS. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2: 11-19.
9. GERSHON, R.K. & K. KONDO. 1971. Infectious immunological tolerance. Immunology 21: 903-914.
10. SAKAGUCHI, S. et al. 2006. Foxp3+ CD4+ CD25+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212: 8-27.
11. ADA, G. 2001. Vaccines and vaccination. N. Engl. J. Med. 345: 1042-1053.
12. DONNELLY, J.J. et al. 1997. DNA vaccines. Annu. Rev. Immunol. 15: 617-648.
13. ULMER, J.B., B. WAHREN & M.A. LIU. 2006. Gene-based vaccines: recent technical and clinical advances. Trends Mol. Med. 12: 216-221.
14. BAROUCH, D.H. 2006. Rational design of gene-based vaccines. J. Pathol. 208: 283-289.
15. NICHOLS, W.W. et al. 1995. Potential DNA vaccine integration into host cell genome. Ann. N. Y. Acad. Sci. 772: 30-39.
16. WANG, Z. et al. 2004. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther. 11: 711-721.
17. EVANS, G.H. et al. 2006. Gene therapeutic approaches-transfer in vivo. Adv. Drug Del. Rev. 58: 243-258.
18. ZHANG, X. & W.T. GODBEY. 2006. Viral vectors for gene delivery in tissue engineering. Adv. Drug Deliv. Rev. 58: 515-534.
19. HACEIN-BEY-HABINA, S. et al. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348: 255-256.
20. SOMIA, N. & I.N. VERMA. 2000. Gene therapy: trials and tribulations. Nat. Rev. Genet. 1: 91-99.
21. FONTOURA, P., H. GARREN & L. STEINMAN. 2005. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides. Int. Rev. Immunol. 24: 415-446.
22. WAISMAN, A. et al. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2: 899-905.
23. BRACIAK, T.A. et al. 2003. Protection against experimental allergic encephalomyelitis generated by a recombinant adenovirus vector expressing the Vb8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10. J. Immunol. 170: 765-774.
24. CHUNDURU, S.K. et al. 1996. Exploitation of the Vb8.2 TCR in protection against experimental allergic encephalomyelitis using a live vaccinia virus vector. J. Immunol. 156: 4940-4945.
25. LOBELL, A. et al. 1998. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J. Exp. Med. 187: 1543-1548.
26. RUIZ, P.J. et al. 1999. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J. Immunol. 162: 3336-3341.
27. LOBELL, A. et al. 2003. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis involves a T1-biased immune response. J. Immunol. 170: 1806-1813.
28. TISCH, R. et al. 2001. Antigen-specific mediated suppression of B cell autoimmunity mediated by plasmid DNA vaccination. J. Immunol. 166: 2122-2132.
29. COON, B., L.-L. AN, W.J. LINDSAY & M.G. VON HERRATH. 1999. DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104: 189-194.
30. BOT, A. et al. 2001. Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 2959-2955.
31. GALLICHAN, W.S. et al. 1999. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J. Immunol. 163: 1696-1703.
32. EVERY, A.L. et al. 2006. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes. J. Immunol. 176: 4608-4615.
33. SOUKHAREVA, N., Y. JIANG & D.W. SCOTT. 2006. Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of regulatory T cells. Cell. Immunol. 240: 41-46.
34. GLINKA, Y. et al. 2003. Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice. J. Mol. Med. 81: 175-184.
35. LI, A. et al. 2006. Pro-apoptotic DNA vaccination ameliorated new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro. Vaccine 24: 5036-5046.
36. QUINTANA, F.J., P. CARMI & I.R. COHEN. 2002. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide- accelerated diabetes. J. Immunol. 169: 6030-6035.
37. HO, P.P. et al. 2006. Tolerizing DNA vaccines for autoimmune arthritis. Autoimmunity 39: 675-682.
38. HARAOUI, B. 2005. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis. J. Rheumatol. Suppl. 72: 46-47.
39. YOUSSEF, S. et al. 2000. C-C chemokine - encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J. Clin. Invest. 106: 361-371.
40. WILDBAUM, G., S. YOUSSEF & N. KARIN. 2000. A targeted DNA vaccine augments the natural immune response to self TNF-a and suppresses ongoing adjuvant arthritis. 165: 5860-5866.
41. BLANK, M. et al. 2003. TNFalpha DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome. Lupus 12: 546-549.
42. AGARWAL, R.K. et al. 2000. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J. Clin. Invest. 106: 245-252.
43. THEOFILOPOULOS, A.N. et al. 2001. The role of IFN-γ in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res. 3: 136-141.
44. MELO, M.E. et al. 2002. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol. 168: 4788-4795.
45. LEI, T.C., Y. SU & D.W. SCOTT. 2005. Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold. Cell. Immunol. 235: 12-20.
46. HAHN, B. et al. 2001. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44: 432-441.
47. FILACI, G. et al. 2004. Spontaneous transgenesis of human B lymphocytes. Gene Ther. 11: 42-51.